Increased myocardial infarction risk a class effect of NSAIDs
Gespeichert in:
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2005 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© Adis International Ltd 2005 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1495(2005), 1 vom: Juli, Seite 19-20 |
|---|---|
| Übergeordnetes Werk: |
volume:1495 ; year:2005 ; number:1 ; month:07 ; pages:19-20 |
| Links: |
|---|
| DOI / URN: |
10.2165/00128413-200514950-00049 |
|---|
| Katalog-ID: |
SPR035222921 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR035222921 | ||
| 003 | DE-627 | ||
| 005 | 20230519140308.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s2005 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2165/00128413-200514950-00049 |2 doi | |
| 035 | |a (DE-627)SPR035222921 | ||
| 035 | |a (SPR)00128413-200514950-00049-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Increased myocardial infarction risk a class effect of NSAIDs |
| 264 | 1 | |c 2005 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Adis International Ltd 2005 | ||
| 650 | 4 | |a Acute Myocardial Infarction |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Celecoxib |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Naproxen |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Acute Myocardial Infarction |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Rofecoxib |7 (dpeaa)DE-He213 | |
| 773 | 0 | 8 | |i Enthalten in |t Inpharma weekly |d Auckland : ADIS internat., 1975 |g 1495(2005), 1 vom: Juli, Seite 19-20 |w (DE-627)373977859 |w (DE-600)2127607-9 |x 2230-6056 |7 nnns |
| 773 | 1 | 8 | |g volume:1495 |g year:2005 |g number:1 |g month:07 |g pages:19-20 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.2165/00128413-200514950-00049 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_206 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2009 | ||
| 912 | |a GBV_ILN_2011 | ||
| 912 | |a GBV_ILN_2055 | ||
| 912 | |a GBV_ILN_2111 | ||
| 912 | |a GBV_ILN_4305 | ||
| 951 | |a AR | ||
| 952 | |d 1495 |j 2005 |e 1 |c 07 |h 19-20 | ||
| matchkey_str |
article:22306056:2005----::nraemoadaifrtorsals |
|---|---|
| hierarchy_sort_str |
2005 |
| publishDate |
2005 |
| allfields |
10.2165/00128413-200514950-00049 doi (DE-627)SPR035222921 (SPR)00128413-200514950-00049-e DE-627 ger DE-627 rakwb eng Increased myocardial infarction risk a class effect of NSAIDs 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Acute Myocardial Infarction (dpeaa)DE-He213 Celecoxib (dpeaa)DE-He213 Naproxen (dpeaa)DE-He213 Acute Myocardial Infarction (dpeaa)DE-He213 Rofecoxib (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1495(2005), 1 vom: Juli, Seite 19-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1495 year:2005 number:1 month:07 pages:19-20 https://dx.doi.org/10.2165/00128413-200514950-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1495 2005 1 07 19-20 |
| spelling |
10.2165/00128413-200514950-00049 doi (DE-627)SPR035222921 (SPR)00128413-200514950-00049-e DE-627 ger DE-627 rakwb eng Increased myocardial infarction risk a class effect of NSAIDs 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Acute Myocardial Infarction (dpeaa)DE-He213 Celecoxib (dpeaa)DE-He213 Naproxen (dpeaa)DE-He213 Acute Myocardial Infarction (dpeaa)DE-He213 Rofecoxib (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1495(2005), 1 vom: Juli, Seite 19-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1495 year:2005 number:1 month:07 pages:19-20 https://dx.doi.org/10.2165/00128413-200514950-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1495 2005 1 07 19-20 |
| allfields_unstemmed |
10.2165/00128413-200514950-00049 doi (DE-627)SPR035222921 (SPR)00128413-200514950-00049-e DE-627 ger DE-627 rakwb eng Increased myocardial infarction risk a class effect of NSAIDs 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Acute Myocardial Infarction (dpeaa)DE-He213 Celecoxib (dpeaa)DE-He213 Naproxen (dpeaa)DE-He213 Acute Myocardial Infarction (dpeaa)DE-He213 Rofecoxib (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1495(2005), 1 vom: Juli, Seite 19-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1495 year:2005 number:1 month:07 pages:19-20 https://dx.doi.org/10.2165/00128413-200514950-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1495 2005 1 07 19-20 |
| allfieldsGer |
10.2165/00128413-200514950-00049 doi (DE-627)SPR035222921 (SPR)00128413-200514950-00049-e DE-627 ger DE-627 rakwb eng Increased myocardial infarction risk a class effect of NSAIDs 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Acute Myocardial Infarction (dpeaa)DE-He213 Celecoxib (dpeaa)DE-He213 Naproxen (dpeaa)DE-He213 Acute Myocardial Infarction (dpeaa)DE-He213 Rofecoxib (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1495(2005), 1 vom: Juli, Seite 19-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1495 year:2005 number:1 month:07 pages:19-20 https://dx.doi.org/10.2165/00128413-200514950-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1495 2005 1 07 19-20 |
| allfieldsSound |
10.2165/00128413-200514950-00049 doi (DE-627)SPR035222921 (SPR)00128413-200514950-00049-e DE-627 ger DE-627 rakwb eng Increased myocardial infarction risk a class effect of NSAIDs 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Acute Myocardial Infarction (dpeaa)DE-He213 Celecoxib (dpeaa)DE-He213 Naproxen (dpeaa)DE-He213 Acute Myocardial Infarction (dpeaa)DE-He213 Rofecoxib (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1495(2005), 1 vom: Juli, Seite 19-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1495 year:2005 number:1 month:07 pages:19-20 https://dx.doi.org/10.2165/00128413-200514950-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1495 2005 1 07 19-20 |
| language |
English |
| source |
Enthalten in Inpharma weekly 1495(2005), 1 vom: Juli, Seite 19-20 volume:1495 year:2005 number:1 month:07 pages:19-20 |
| sourceStr |
Enthalten in Inpharma weekly 1495(2005), 1 vom: Juli, Seite 19-20 volume:1495 year:2005 number:1 month:07 pages:19-20 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Acute Myocardial Infarction Celecoxib Naproxen Rofecoxib |
| isfreeaccess_bool |
false |
| container_title |
Inpharma weekly |
| publishDateDaySort_date |
2005-07-01T00:00:00Z |
| hierarchy_top_id |
373977859 |
| id |
SPR035222921 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035222921</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519140308.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2005 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200514950-00049</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035222921</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200514950-00049-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Increased myocardial infarction risk a class effect of NSAIDs</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2005</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acute Myocardial Infarction</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Celecoxib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Naproxen</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acute Myocardial Infarction</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rofecoxib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1495(2005), 1 vom: Juli, Seite 19-20</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1495</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:1</subfield><subfield code="g">month:07</subfield><subfield code="g">pages:19-20</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200514950-00049</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1495</subfield><subfield code="j">2005</subfield><subfield code="e">1</subfield><subfield code="c">07</subfield><subfield code="h">19-20</subfield></datafield></record></collection>
|
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)373977859 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
2230-6056 |
| topic_title |
Increased myocardial infarction risk a class effect of NSAIDs Acute Myocardial Infarction (dpeaa)DE-He213 Celecoxib (dpeaa)DE-He213 Naproxen (dpeaa)DE-He213 Rofecoxib (dpeaa)DE-He213 |
| topic |
misc Acute Myocardial Infarction misc Celecoxib misc Naproxen misc Rofecoxib |
| spellingShingle |
misc Acute Myocardial Infarction misc Celecoxib misc Naproxen misc Rofecoxib Increased myocardial infarction risk a class effect of NSAIDs |
| topic_unstemmed |
misc Acute Myocardial Infarction misc Celecoxib misc Naproxen misc Rofecoxib |
| topic_browse |
misc Acute Myocardial Infarction misc Celecoxib misc Naproxen misc Rofecoxib |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Inpharma weekly |
| hierarchy_parent_id |
373977859 |
| hierarchy_top_title |
Inpharma weekly |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)373977859 (DE-600)2127607-9 |
| title |
Increased myocardial infarction risk a class effect of NSAIDs |
| ctrlnum |
(DE-627)SPR035222921 (SPR)00128413-200514950-00049-e |
| title_full |
Increased myocardial infarction risk a class effect of NSAIDs |
| journal |
Inpharma weekly |
| journalStr |
Inpharma weekly |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2005 |
| contenttype_str_mv |
txt |
| container_start_page |
19 |
| container_volume |
1495 |
| format_se |
Elektronische Aufsätze |
| doi_str_mv |
10.2165/00128413-200514950-00049 |
| title_sort |
increased myocardial infarction risk a class effect of nsaids |
| title_auth |
Increased myocardial infarction risk a class effect of NSAIDs |
| abstract |
© Adis International Ltd 2005 |
| abstractGer |
© Adis International Ltd 2005 |
| abstract_unstemmed |
© Adis International Ltd 2005 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 |
| container_issue |
1 |
| title_short |
Increased myocardial infarction risk a class effect of NSAIDs |
| url |
https://dx.doi.org/10.2165/00128413-200514950-00049 |
| remote_bool |
true |
| ppnlink |
373977859 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.2165/00128413-200514950-00049 |
| up_date |
2024-07-03T13:54:46.019Z |
| _version_ |
1803566329127501824 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035222921</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519140308.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2005 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200514950-00049</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035222921</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200514950-00049-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Increased myocardial infarction risk a class effect of NSAIDs</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2005</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acute Myocardial Infarction</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Celecoxib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Naproxen</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acute Myocardial Infarction</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rofecoxib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1495(2005), 1 vom: Juli, Seite 19-20</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1495</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:1</subfield><subfield code="g">month:07</subfield><subfield code="g">pages:19-20</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200514950-00049</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1495</subfield><subfield code="j">2005</subfield><subfield code="e">1</subfield><subfield code="c">07</subfield><subfield code="h">19-20</subfield></datafield></record></collection>
|
| score |
7.399349 |